saikosaponin
repres
group
oleanan
deriv
usual
glucosid
found
number
plant
famili
saikosaponin
isol
medicin
plant
bupleurum
spp
heteromorpha
spp
scrophularia
scorodonia
report
possess
variou
biolog
activ
specif
antihepat
antinephr
antihepatoma
antiinflamm
immunomodul
antibacteri
effect
antivir
activ
concentr
mmoll
strongest
activ
note
saikosaponin
b
ic
mmoll
interestingli
saikosaponin
cellular
cytotox
cc
concentr
mmoll
select
index
si
b
cc
mmoll
si
exhibit
cytotox
effect
target
cell
concentr
achiev
antivir
activ
timeofaddit
studi
saikosaponin
b
mmoll
significantli
inhibit
human
coronaviru
infect
follow
addit
variou
time
preinfect
h
coinfect
h
postinfect
h
furthermor
saikosaponin
b
also
show
inhibitori
effect
viral
attach
penetr
present
result
indic
saikosaponin
b
potent
anticoronavir
activ
mode
action
possibl
involv
interfer
earli
stage
viral
replic
absorpt
penetr
viru
nosocomi
respiratori
viral
infect
nrvi
increasingli
document
paediatr
unit
common
aetiolog
viral
agent
infect
respiratori
system
respiratori
syncyti
viru
influenza
viru
rhinoviru
recent
novel
human
coronaviru
hcov
identifi
caus
agent
sever
acut
respiratori
syndrom
sar
hcov
recogn
past
year
two
recent
recogn
import
caus
nrvi
highrisk
infant
past
decad
number
phytochem
report
possess
potent
antivir
activ
saikosaponin
repres
group
oleanan
deriv
usual
glucosid
found
number
plant
famili
saikosaponin
isol
medicin
plant
bupleurum
spp
heteromorpha
spp
scrophularia
scorodonia
report
possess
variou
biolog
activ
name
antihepat
antinephr
antihepatoma
antiinflamm
antibacteri
effect
well
abl
modul
immun
function
furthermor
saikosaponin
b
c
shown
activ
human
immunodefici
viru
hiv
measl
influenza
viru
herp
simplex
viru
varicellazost
viru
attempt
find
new
antihcov
compound
conduct
seri
experi
investig
antivir
activ
mode
action
saikosaponin
vitro
actinomycin
dimethylsulphoxid
dmso
saikosaponin
b
c
fig
purchas
sigma
chemic
st
loui
mo
usa
phenylamino
hydroxid
xtt
kit
purchas
roch
diagnost
mannheim
germani
actinomycin
posit
control
saikosaponin
puriti
greater
dissolv
dmso
dilut
rpmi
medium
sigma
chemic
requir
concentr
final
concentr
dmso
greater
obtain
american
type
cultur
collect
atcc
rockvil
md
usa
human
fetal
lung
fibroblast
atcc
use
target
cell
viral
infect
cell
grown
rpmi
medium
supplement
fetal
calf
serum
fc
unitsml
penicillin
g
mgml
streptomycin
mgml
amphotericin
b
humidifi
atmospher
co
viru
titr
determin
cytopath
effect
express
tissu
cultur
infect
dose
tcid
per
ml
virus
store
use
cell
seed
onto
plate
concentr
cell
volum
mlwell
differ
concentr
saikosaponin
b
c
appli
cultur
well
triplic
dimethylsulphoxid
actinomycin
blackwel
publish
asia
pti
ltd
use
neg
posit
control
respect
incub
co
day
mixtur
ml
phenazin
methosulph
pm
electroncoupl
reagent
ml
xtt
ad
well
tray
incub
h
allow
product
xtt
formazan
absorb
determin
elisa
reader
multiskan
ex
labsystem
helsinki
finland
test
wavelength
nm
refer
wavelength
nm
data
calcul
percentag
inhibit
use
follow
formula
inhibit
ata
refer
absorb
test
substanc
solvent
control
respect
cellular
cytotox
cc
concentr
test
substanc
calcul
accord
chiang
et
al
select
index
si
calcul
ratio
cc
ec
antivir
activ
pure
compound
evalu
use
xtt
method
cell
treat
trypsin
seed
onto
plate
concentr
cellsml
volum
mlwell
incub
co
overnight
ml
test
viru
tcid
ad
cell
incub
h
xtt
test
perform
describ
percentag
protect
calcul
atv
absorb
viral
infect
cell
presenc
test
compound
acv
acd
absorb
viru
control
cell
control
respect
antivir
concentr
effect
ec
defin
concentr
achiev
inhibit
virusinduc
cytopath
effect
number
virus
use
experi
base
infect
target
cell
tcid
viru
produc
xtt
formazan
product
uninfect
control
cell
twenti
microlitr
tcid
per
well
absorb
onto
confluent
monolay
cell
h
follow
addit
differ
concentr
saikosaponin
b
mmoll
cultur
cell
variou
time
preinfect
h
coinfect
h
postinfect
h
viru
cell
day
incub
xtt
test
perform
antivir
activ
determin
describ
attach
assay
conduct
accord
procedur
describ
albin
et
al
de
logu
et
al
minor
modif
briefli
cell
monolay
grown
cultur
plate
prechil
h
medium
aspir
cell
monolay
infect
tcid
absenc
presenc
variou
concentr
saikosaponin
b
mmoll
incub
infect
cell
monolay
h
medium
aspir
remov
unabsorb
viru
cell
monolay
wash
phosphatebuff
salin
pb
three
time
overlaid
fc
medium
day
incub
xtt
test
perform
describ
absorb
measur
test
wavelength
nm
refer
wavelength
nm
use
elisa
reader
percentag
inhibit
attach
calcul
odt
od
optic
densiti
test
substanc
solvent
control
respect
penetr
assay
cell
perform
accord
publish
procedur
minor
modif
cell
monolay
grown
cultur
plate
prechil
h
cell
monolay
infect
tcid
incub
h
allow
attach
mmoll
saikosaponin
b
solvent
control
dmso
ad
cultur
medium
infect
cell
monolay
incub
maxim
penetr
viru
min
interv
infect
cell
monolay
treat
acid
pb
ph
min
inactiv
nonpenetr
viru
immedi
addit
pb
ph
neutral
acid
pb
ph
neutral
pb
remov
cell
monolay
overlaid
fc
medium
day
incub
xtt
test
perform
describ
absorb
measur
test
wavelength
nm
refer
wavelength
nm
use
elisa
reader
percentag
inhibit
penetr
calcul
odt
od
indic
optic
densiti
test
substanc
solvent
control
respect
result
express
three
independ
experi
statist
analysi
perform
oneway
anova
follow
least
signific
differ
lsd
multipl
rang
test
differ
test
compound
control
evalu
use
student
ttest
p
consid
statist
differ
first
evalu
cytotox
saikosaponin
b
c
actinomycin
cell
use
xtt
assay
result
show
saikosaponin
b
c
cytotox
effect
cell
concentr
mmoll
fig
interestingli
cell
viabil
note
saikosaponin
b
c
use
concentr
mmoll
furthermor
visibl
chang
cell
morpholog
cell
densiti
observ
concentr
test
concentr
estim
reduc
cell
viabil
cc
variou
saikosaponin
rang
mmoll
better
actinomycin
posit
control
cc
moll
tabl
give
ec
si
valu
saikosaponin
b
c
inhibit
infect
saikosaponin
b
show
strongest
anticoronavir
activ
best
si
valu
investig
mechanist
effect
drug
viral
infect
order
investig
mechan
saikosaponin
b
inhibit
infect
viru
studi
conduct
investig
timecours
effect
variou
concentr
saikosaponin
b
mmoll
h
h
viral
infect
result
show
saikosaponin
b
decreas
infect
doseand
timedepend
manner
fig
addit
saikosaponin
b
note
inhibit
viral
infect
effici
ad
viral
adsorpt
mmoll
data
three
independ
experi
p
compar
saikosaponin
p
compar
saikosaponin
b
p
compar
saikosaponin
c
student
ttest
cc
concentr
reduc
growth
target
cell
ec
inhibitori
concentr
compound
produc
inhibit
virusinduc
cytopath
effect
si
select
index
cc
ec
actinomycin
use
posit
control
accord
result
timeofaddit
studi
saikosaponin
b
appear
affect
earli
stage
infect
observ
suggest
saikosaponin
b
may
disturb
earli
event
infect
includ
viral
attach
penetr
thu
effect
saikosaponin
b
viral
attach
penetr
investig
result
show
attach
significantli
inhibit
saikosaponin
b
dosedepend
manner
fig
percentag
attach
inhibit
concentr
mmoll
saikosaponin
b
respect
result
suggest
saikosaponin
b
prevent
attach
host
cell
fig
penetr
host
cell
inhibit
mmoll
saikosaponin
b
timedepend
manner
inhibit
rate
min
respect
fig
observ
suggest
saikosaponin
b
also
prevent
penetr
host
cell
present
studi
demonstr
saikosaponin
b
c
possess
activ
saikosaponin
b
exhibit
strongest
potenc
furthermor
saikosaponin
b
show
cytotox
effect
cell
viabil
timecours
studi
reveal
activ
saikosaponin
b
higher
ad
viru
enter
host
cell
ad
viru
infect
host
cell
result
suggest
saikosaponin
b
may
interfer
earli
stage
viral
replic
adsorpt
penetr
viru
natur
product
plant
microorgan
tradit
provid
pharmaceut
industri
mani
import
lead
search
new
drug
past
decad
mani
compound
isol
medicin
plant
found
possess
inhibitori
activ
virus
viral
infect
remain
seriou
problem
mani
countri
coupl
recent
outbreak
sar
effect
drug
avail
scientist
worldwid
search
new
cure
diseas
present
studi
indic
saikosaponin
b
potent
activ
investig
better
understand
molecular
mode
action
saikosaponin
b
could
novel
lead
develo
potenti
chemoprevent
agent
viral
infect
previou
studi
triterpenoid
saponin
shown
possess
mark
antivir
activ
concentr
saponin
show
cytotox
effect
vero
cell
mechan
antivir
activ
suggest
associ
earli
event
viral
infecti
cycl
inhibit
virushost
cell
attach
base
direct
interact
saikosaponin
surfac
membran
host
cell
present
studi
postul
antivir
activ
saikosaponin
b
could
direct
inactiv
viru
direct
interact
host
cell
membran
result
morpholog
chang
cell
membran
event
could
consequ
lead
arrest
viral
adsorpt
penetr
previou
studi
although
saikosaponin
shown
inhibitori
effect
herp
simplex
type
vitro
mechan
action
elucid
anoth
studi
saikosaponin
c
show
activ
inhibit
hepat
b
viru
dna
replic
wherea
saikosaponin
abl
inactiv
measl
fig
effect
saikosaponin
b
attach
cell
prechil
h
follow
inocul
tcid
cell
monolay
absenc
presenc
test
compound
h
incub
percentag
attach
test
compoundtr
group
evalu
use
xtt
assay
data
three
independ
experi
p
differ
dose
saikosaponin
b
oneway
anova
effect
saikosaponin
b
penetr
cell
cell
monolay
prechil
h
infect
tcid
h
h
incub
mmol
l
saikosaponin
b
ad
cultur
min
interv
extracellular
viru
inactiv
acid
phosphatebuff
salin
pb
ph
min
pb
ph
ad
neutral
acid
pb
neutral
pb
remov
fetal
calf
serum
ad
percentag
penetr
viru
evalu
use
xtt
assay
data
three
independ
experi
p
differ
time
point
oneway
anova
viru
herp
simplex
viru
vitro
phytochem
studi
baicalein
report
function
block
epiderm
growth
factor
receptor
tyrosin
kinas
activ
human
cytomegaloviru
hcmv
nuclear
transloc
wherea
genistein
antivir
activ
genistein
hcmv
infect
shown
inhibit
earli
late
hcmv
gene
express
quercetin
two
deriv
kaempferol
appear
inhibit
hiv
infect
prevent
bind
allophycocyanin
abl
delay
viral
rna
synthesi
infect
cell
knowledg
present
studi
first
demonstr
saikosaponin
b
inhibit
viral
absorpt
penetr
saikosaponin
b
inhibit
attach
host
cell
consequ
led
arrest
viral
absorpt
eventu
viral
penetr
addit
affect
viral
attach
saikosaponin
b
also
appear
prevent
penetr
host
cell
demonstr
penetr
experi
fail
attach
host
cell
addit
saikosaponin
observ
block
penetr
suggest
saikosaponin
b
affect
viral
penetr
process
possibl
detach
viru
alreadi
bound
cell
perhap
disturb
viral
glycoprotein
conclus
present
studi
saikosaponin
b
found
inhibit
viral
infect
concentr
mmoll
less
ii
inhibit
viral
attach
cell
dosedepend
manner
iii
block
viral
penetr
cell
iv
interfer
earli
stage
viral
replic
viru
absorpt
penetr
multipl
mode
action
saikosaponin
b
merit
investig
